166 related articles for article (PubMed ID: 18401866)
1. Release of prostaglandin E(1) from N-(2-hydroxypropyl)methacrylamide copolymer conjugates by bone cells.
Pan H; Liu J; Dong Y; Sima M; Kopecková P; Brandi ML; Kopecek J
Macromol Biosci; 2008 Jul; 8(7):599-605. PubMed ID: 18401866
[TBL] [Abstract][Full Text] [Related]
2. Water-soluble HPMA copolymer--prostaglandin E1 conjugates containing a cathepsin K sensitive spacer.
Pan H; Kopecková P; Wang D; Yang J; Miller S; Kopecek J
J Drug Target; 2006 Jul; 14(6):425-35. PubMed ID: 17092842
[TBL] [Abstract][Full Text] [Related]
3. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.
Omelyanenko V; Kopecková P; Gentry C; Kopecek J
J Control Release; 1998 Apr; 53(1-3):25-37. PubMed ID: 9741911
[TBL] [Abstract][Full Text] [Related]
4. Stability in plasmas of various species of HPMA copolymer-PGE1 conjugates.
Pan H; Kopecková P; Liu J; Wang D; Miller SC; Kopecek J
Pharm Res; 2007 Dec; 24(12):2270-80. PubMed ID: 17899324
[TBL] [Abstract][Full Text] [Related]
5. Cysteine-proteinase localization in osteoclasts: an immunocytochemical study.
Sasaki T; Ueno-Matsuda E
Cell Tissue Res; 1993 Jan; 271(1):177-9. PubMed ID: 8443832
[TBL] [Abstract][Full Text] [Related]
6. Passive and active hepatoma tumor targeting of new N-(2-hydroxypropyl)methacrylamide copolymer conjugates: synthesis, characterization, and evaluation in vitro and in vivo.
Yuan J; Yuan B; Guo H; Zeng X; Wang X; Liao S; Li J; Jia Z; Song F; Wang F
J Biomater Sci Polym Ed; 2013; 24(12):1472-83. PubMed ID: 23829459
[TBL] [Abstract][Full Text] [Related]
7. N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice.
Seymour LW; Ulbrich K; Wedge SR; Hume IC; Strohalm J; Duncan R
Br J Cancer; 1991 Jun; 63(6):859-66. PubMed ID: 1648946
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and pharmacokinetic studies of bone-targeting N-(2-hydroxypropyl)methacrylamide copolymer-alendronate conjugates.
Pan H; Sima M; Kopecková P; Wu K; Gao S; Liu J; Wang D; Miller SC; Kopecek J
Mol Pharm; 2008; 5(4):548-58. PubMed ID: 18505266
[TBL] [Abstract][Full Text] [Related]
9. Specific biological functions of vacuolar-type H(+)-ATPase and lysosomal cysteine proteinase, cathepsin K, in osteoclasts.
Sahara T; Itoh K; Debari K; Sasaki T
Anat Rec A Discov Mol Cell Evol Biol; 2003 Feb; 270(2):152-61. PubMed ID: 12524690
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cathepsin K with lysosomotropic macromolecular inhibitors.
Wang D; Pechar M; Li W; Kopecková P; Brömme D; Kopecek J
Biochemistry; 2002 Jul; 41(28):8849-59. PubMed ID: 12102627
[TBL] [Abstract][Full Text] [Related]
11. PDEPT: polymer-directed enzyme prodrug therapy. I. HPMA copolymer-cathepsin B and PK1 as a model combination.
Satchi R; Connors TA; Duncan R
Br J Cancer; 2001 Sep; 85(7):1070-6. PubMed ID: 11592781
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical study of cathepsin L and rat salivary cystatin-3 in rat osteoclasts treated with E-64 in vivo.
Moroi R; Yamaza T; Nishiura T; Nishimura Y; Terada Y; Abe K; Himeno M; Tanaka T
Arch Oral Biol; 1997 Apr; 42(4):305-15. PubMed ID: 9222450
[TBL] [Abstract][Full Text] [Related]
13. Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells.
David A; Kopecková P; Minko T; Rubinstein A; Kopecek J
Eur J Cancer; 2004 Jan; 40(1):148-57. PubMed ID: 14687799
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the endosomal and lysosomal distribution of cathepsins B, L and S in human monocytes/macrophages.
Schmid H; Sauerbrei R; Schwarz G; Weber E; Kalbacher H; Driessen C
Biol Chem; 2002; 383(7-8):1277-83. PubMed ID: 12437117
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence microscopic demonstration of cathepsin K activity as the major lysosomal cysteine proteinase in osteoclasts.
Kamiya T; Kobayashi Y; Kanaoka K; Nakashima T; Kato Y; Mizuno A; Sakai H
J Biochem; 1998 Apr; 123(4):752-9. PubMed ID: 9538271
[TBL] [Abstract][Full Text] [Related]
16. Estrogen modulation of osteoclast lysosomal enzyme secretion.
Kremer M; Judd J; Rifkin B; Auszmann J; Oursler MJ
J Cell Biochem; 1995 Feb; 57(2):271-9. PubMed ID: 7759564
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin G recruits osteoclast precursors via proteolytic activation of protease-activated receptor-1.
Wilson TJ; Nannuru KC; Singh RK
Cancer Res; 2009 Apr; 69(7):3188-95. PubMed ID: 19293192
[TBL] [Abstract][Full Text] [Related]
18. Lysosomal enzyme trafficking between phagosomes, endosomes, and lysosomes in J774 macrophages. Enrichment of cathepsin H in early endosomes.
Claus V; Jahraus A; Tjelle T; Berg T; Kirschke H; Faulstich H; Griffiths G
J Biol Chem; 1998 Apr; 273(16):9842-51. PubMed ID: 9545324
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment.
Larson N; Yang J; Ray A; Cheney DL; Ghandehari H; Kopeček J
Int J Pharm; 2013 Sep; 454(1):435-43. PubMed ID: 23827653
[TBL] [Abstract][Full Text] [Related]
20. Intracellular machinery for matrix degradation in bone-resorbing osteoclasts.
Vääräniemi J; Halleen JM; Kaarlonen K; Ylipahkala H; Alatalo SL; Andersson G; Kaija H; Vihko P; Väänänen HK
J Bone Miner Res; 2004 Sep; 19(9):1432-40. PubMed ID: 15312243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
